%0
Generic
%T
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate‐risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006‐intermediate‐risk trial
%A Bouvier, Anne
%A Hamel, Jean‐François
%A Delaunay, Jacques
%A Delabesse, Eric
%A Dumas, Pierre‐Yves
%A Ledoux, Marie‐Pierre
%A Peterlin, Pierre
%A Luquet, Isabelle
%A Roth Guepin, Gabrielle
%A Bulabois, Claude Eric
%A Gallego Hernanz, Maria Pilar
%A Guillerm, Gaëlle
%A Guieze, Romain
%A Hicheri, Yosr
%A Simand, Célestine
%A Himberlin, Chantal
%A Hunault‐Berger, Mathilde
%A Bernard, Marc
%A Jourdan, Eric
%A Caillot, Denis
%A Dorvaux, Véronique
%A Tavernier, Emmanuelle
%A Daguindau, Etienne
%A Banos, Anne
%A Ojeda‐Uribe, Mario
%A Gyan, Emmanuel
%A Alexis, Magda
%A Marolleau, Jean‐Pierre
%A Turlure, Pascal
%A Bouscary, Didier
%A Humbrecht, Catherine
%A Zerazhi, Hacène
%A Béné, Marie‐Christine
%A Pigneux, Arnaud
%A Carre, Martin
%A Ifrah, Norbert
%A Blanchet, Odile
%A Vey, Norbert
%A Récher, Christian
%A Cornillet‐Lefèbvre, Pascale
%I Wiley
%@ 0902-4441
%@ 1600-0609
%K Hematology
%K General Medicine
%D 2021
%C Wiley
%U http://slubdd.de/katalog?TN_libero_mab2